ATROVENT 0.25 mg/1 ml for children, solution for inhalation by nebulizer in a single-dose container 30 single-dose containers of 1 ml
Active ingredients: Ipratropium bromide, Anhydrous ipratropium bromide
Commercialized according to BDPMDispensing in France: Prescription only
Solution for inhalation by nebulizer30 single-dose containers of 1 mlinhalée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ATROVENT 0,25 mg/1 ml ENFANTS, solution pour inhalation par nébuliseur en récipient unidose
- Pharmaceutical form
- solution pour inhalation par nébuliseur
- Route of administration
- inhalée
- Presentation description
- 30 récipient(s) unidose(s) polyéthylène de 1 ml
- Marketing authorisation holder
- BOEHRINGER INGELHEIM FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 30 Jan 2006
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by specialists only
- Emergency use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67838060CIP73658131CIP133400936581319Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BROMURE D'IPRATROPIUMsolution | 0,261 mg · un récipient unidose | SA |
| BROMURE D'IPRATROPIUM ANHYDREsolution | 0,250 mg · un récipient unidose | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.